The proliferation of false medicines represents a deeply concerning challenge facing the global healthcare landscape. These bogus products, often mimicking legitimate medications, pose a significant danger to consumer safety, undermining therapy effectiveness and potentially leading to severe negative health consequences. Motivated by substantial m